Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

A man developed skin issues from cancer medication, which improved with specific treatments.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

The new drug delivery system effectively targets lung cancer cells.

Some cancer treatments can cause permanent hair loss.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

Targeted cancer therapies often cause serious skin problems that need careful management.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Lack of functional CYLD in mice leads to early aging and cancer.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.